Rethinking Clinical Trials
Jonathan emphasizes the importance of thoughtful enrollment in clinical trials, advocating for a focus on those most affected by diseases. He challenges the secrecy surrounding study drugs, suggesting that transparency can enhance patient choice and involvement. Additionally, he calls for a connection between clinical care and research, highlighting the need for a more inclusive approach to scientific innovation.In this clip
From this podcast
Short Wave
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
Related Questions